CA 19-9, CA 125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 48 (1) , 77-83
- https://doi.org/10.1016/0304-3835(89)90205-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Comparison Between Tissue and Serum Content of CA 125, CA 19–9, and Carcinoembryonic Antigen in Ovarian TumorsInternational Journal of Gynecological Pathology, 1989
- Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: A comparison with CA 19-9 and CEAGynecologic Oncology, 1989
- Immunochemical and biochemical relationship between human pregnancy-associated secreted endometrial α1- and α2-globulins (α1- and α2-PEG) and the soluble placental proteins 12 and 14 (PP12 and PP14)Placenta, 1986
- Simultaneous inhibition of endogenous avidin-binding activity and peroxidase applicable for the avidin-biotin system using monoclonal antibodiesHistochemistry and Cell Biology, 1985
- Carcinoembryonic Antigen (CEA) and Carbohydrate Determinant 19–9 (CA 19–9) Localization in 121 Primary and Metastatic Ovarian TumorsInternational Journal of Gynecological Pathology, 1982
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Colorectal carcinoma antigens detected by hybridoma antibodiesSomatic Cell and Molecular Genetics, 1979
- Immunohistochemical Demonstration of Several Tumour Markers in Neoplastic and Preneoplastic States of the Uterine MucosaGynecologic and Obstetric Investigation, 1978